Regeneron Pharmaceuticals Inc 2024 Sustainability Report
Company: Regeneron Pharmaceuticals Inc
Sector: Manufacturing
Country: United States
Year: 2024
Type: Sustainability Report
Pages: 71
The report describes Regeneron's first double materiality assessment, completed in 2023, and its 2024 progress across responsibility focus areas. It reports a 43% reduction in combined Scope 1 and 2 market-based emissions intensity against the 2016 baseline, alongside 22% renewable energy usage and 8,650 Metric Tons of waste generated. The workforce totaled 15,106 employees, while the occupational safety table reported zero fatalities in 2024.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.